Literature DB >> 16785228

Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors.

Rositsa I Koleva1, Barbara A Conley, Diana Romero, Kristin S Riley, Jarrod A Marto, Andreas Lux, Calvin P H Vary.   

Abstract

Determination of the functional relationship between the transforming growth factor-beta (TGFbeta) receptor proteins endoglin and ALK1 is essential to the understanding of the human vascular disease, hereditary hemorrhagic telangiectasia. TGFbeta1 caused recruitment of ALK1 into a complex with endoglin in human umbilical vein endothelial cells (HUVECs). Therefore, we examined TGFbeta receptor-dependent phosphorylation of endoglin by the constitutively active forms of the TGFbeta type I receptors ALK1, ALK5, and the TGFbeta type II receptor, TbetaRII. Of these receptors, TbetaRII preferentially phosphorylated endoglin on cytosolic domain serine residues Ser(634) and Ser(635). Removal of the carboxyl-terminal tripeptide of endoglin, which comprises a putative PDZ-liganding motif, dramatically increased endoglin serine phosphorylation by all three receptors, suggesting that the PDZ-liganding motif is important for the regulation of endoglin phosphorylation. Constitutively active (ca)ALK1, but not caALK5, phosphorylated endoglin on cytosolic domain threonine residues. caALK1-mediated threonine phosphorylation required prior serine phosphorylation, suggesting a sequential mechanism of endoglin phosphorylation. Wild-type, but not a threonine phosphorylation-defective endoglin mutant blocked cell detachment and the antiproliferative effects of caALK1 expressed in HUVECs. These results suggest that ALK1 is a preferred TGFbeta receptor kinase for endoglin threonine phosphorylation in HUVECs and indicate a role for endoglin phosphorylation in the regulation of endothelial cell adhesion and growth by ALK1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785228     DOI: 10.1074/jbc.M601288200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.

Authors:  Yuefeng Tang; Xuehui Yang; Robert E Friesel; Calvin P H Vary; Lucy Liaw
Journal:  J Vasc Res       Date:  2011-08-11       Impact factor: 1.934

Review 2.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

3.  Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.

Authors:  Angela J Ziebarth; Somaira Nowsheen; Adam D Steg; Monjri M Shah; Ashwini A Katre; Zachary C Dobbin; Hee-Dong Han; Gabriel Lopez-Berestein; Anil K Sood; Michael Conner; Eddy S Yang; Charles N Landen
Journal:  Clin Cancer Res       Date:  2012-11-12       Impact factor: 12.531

4.  Endoglin regulates cancer-stromal cell interactions in prostate tumors.

Authors:  Diana Romero; Christine O'Neill; Aleksandra Terzic; Liangru Contois; Kira Young; Barbara A Conley; Raymond C Bergan; Peter C Brooks; Calvin P H Vary
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

5.  Modulation of TGF-β signaling by endoglin in murine hemangioblast development and primitive hematopoiesis.

Authors:  Liying Zhang; Alessandro Magli; Jacquelyn Catanese; Zhaohui Xu; Michael Kyba; Rita C R Perlingeiro
Journal:  Blood       Date:  2011-05-20       Impact factor: 22.113

6.  Endoglin in liver fibrosis.

Authors:  Kenneth W Finnson; Anie Philip
Journal:  J Cell Commun Signal       Date:  2011-12-01       Impact factor: 5.782

Review 7.  Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.

Authors:  Steffen K Meurer; Muhammad Alsamman; David Scholten; Ralf Weiskirchen
Journal:  World J Biol Chem       Date:  2014-05-26

8.  Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.

Authors:  Rodrigo Panno Basilio-de-Oliveira; Vera Lucia Nunes Pannain
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

9.  BMP9 regulates endoglin-dependent chemokine responses in endothelial cells.

Authors:  Kira Young; Barbara Conley; Diana Romero; Eric Tweedie; Christine O'Neill; Ilka Pinz; Louise Brogan; Volkhard Lindner; Lucy Liaw; Calvin P H Vary
Journal:  Blood       Date:  2012-09-26       Impact factor: 22.113

10.  Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis.

Authors:  Maria L Mancini; Aleksandra Terzic; Barbara A Conley; Leif H Oxburgh; Teodora Nicola; Calvin P H Vary
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.